These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31712958)

  • 1. Glucose dysregulation in patients with iron overload: is there a relationship with quantitative pancreas and liver iron and fat content measured by MRI?
    Shur J; Kannengiesser SAR; Menezes R; Ward R; Kuo K; Jhaveri K
    Eur Radiol; 2020 Mar; 30(3):1616-1623. PubMed ID: 31712958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of pancreatic iron overload and fat infiltration and their correlation with glucose disturbance in pediatric thalassemia major patients.
    Huang J; Shen J; Yang Q; Cheng Z; Chen X; Yu T; Zhong J; Su Y; Guo H; Liang B
    Quant Imaging Med Surg; 2021 Feb; 11(2):665-675. PubMed ID: 33532266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of hepatic iron in patients suspected of coexisting iron overload and steatosis using multi-echo single-voxel magnetic resonance spectroscopy: Comparison with fat-saturated multi-echo gradient echo sequence.
    Lin H; Fu C; Kannengiesser S; Cheng S; Shen J; Dong H; Yan F
    J Magn Reson Imaging; 2018 Jul; 48(1):205-213. PubMed ID: 29513377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification.
    Lin H; Wei H; He N; Fu C; Cheng S; Shen J; Wang B; Yan X; Liu C; Yan F
    Eur Radiol; 2018 Aug; 28(8):3494-3504. PubMed ID: 29470640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Feasibility of Magnetic Resonance Imaging for Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal Cortex R2* and Proton Density Fat Fraction in Transfusion-Related Iron Overload.
    İdilman İS; Gümrük F; Haliloğlu M; Karçaaltıncaba M
    Turk J Haematol; 2016 Mar; 33(1):21-7. PubMed ID: 26376710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of liver iron overload with R2* relaxometry with versus without fat suppression: both are clinically accurate but there are differences.
    Plaikner M; Kremser C; Zoller H; Jaschke W; Steurer M; Viveiros A; Henninger B
    Eur Radiol; 2020 Nov; 30(11):5826-5833. PubMed ID: 32535737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic iron and fat assessment by MRI-R2* in patients with iron overload diseases.
    Pfeifer CD; Schoennagel BP; Grosse R; Wang ZJ; Graessner J; Nielsen P; Adam G; Fischer R; Yamamura J
    J Magn Reson Imaging; 2015 Jul; 42(1):196-203. PubMed ID: 25236606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of MRI technique on clinical decision-making in patients with liver iron overload: comparison of FerriScan- versus R2*-derived liver iron concentration.
    Sussman MS; Ward R; Kuo KHM; Tomlinson G; Jhaveri KS
    Eur Radiol; 2020 Apr; 30(4):1959-1968. PubMed ID: 31953658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Iron Quantification Using a Free-Breathing 3D Radial Gradient Echo Technique and Validation With a 2D Biopsy-Calibrated R
    Rohani SC; Morin CE; Zhong X; Kannengiesser S; Shrestha U; Goode C; Holtrop J; Khan A; Loeffler RB; Hankins JS; Hillenbrand CM; Tipirneni-Sajja A
    J Magn Reson Imaging; 2022 May; 55(5):1407-1416. PubMed ID: 34545639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic iron in pediatric transfusion-dependent beta-thalassemia patients: A longitudinal MRI study.
    Meloni A; Pistoia L; Putti MC; Longo F; Corigliano E; Ricchi P; Rossi V; Casini T; Righi R; Renne S; Peritore G; Barbuto L; Positano V; Cademartiri F
    Pediatr Blood Cancer; 2024 May; 71(5):e30923. PubMed ID: 38385860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major.
    Meloni A; Nobile M; Keilberg P; Positano V; Santarelli MF; Pistoia L; Spasiano A; Casini T; Putti MC; Cuccia L; Bitti PP; Messina G; Peritore G; Renne S; Grassedonio E; Quaia E; Cademartiri F; Pepe A
    Eur Radiol; 2023 Oct; 33(10):7215-7225. PubMed ID: 37115218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: An Italian multicentre study.
    Pistoia L; Meloni A; Allò M; Spasiano A; Messina G; Sorrentino F; Gamberini MR; Ermini A; Renne S; Fina P; Peritore G; Positano V; Pepe A; Cademartiri F
    Eur J Haematol; 2022 Sep; 109(3):289-297. PubMed ID: 35690882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
    Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
    Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of liver fat in the presence of iron with MRI using T2* correction: a clinical approach.
    Henninger B; Kremser C; Rauch S; Eder R; Judmaier W; Zoller H; Michaely H; Schocke M
    Eur Radiol; 2013 Jun; 23(6):1643-9. PubMed ID: 23334458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients.
    de Assis RA; Ribeiro AA; Kay FU; Rosemberg LA; Nomura CH; Loggetto SR; Araujo AS; Fabron Junior A; de Almeida Veríssimo MP; Baldanzi GR; Espósito BP; Baroni RH; Wood JC; Hamerschlak N
    Eur J Radiol; 2012 Jul; 81(7):1465-70. PubMed ID: 21501938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with β-thalassemia major.
    Bas M; Gumruk F; Gonc N; Cetin M; Tuncer M; Hazırolan T; Yildirim G; Karabulut E; Unal S
    Ann Hematol; 2015 Jul; 94(7):1099-104. PubMed ID: 25740381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Inline R2* MRI versus FerriScan for liver iron quantification in patients on chelation therapy for iron overload: preliminary results.
    Healy GM; Kannengiesser SAR; Espin-Garcia O; Ward R; Kuo KHM; Jhaveri KS
    Eur Radiol; 2021 Dec; 31(12):9296-9305. PubMed ID: 34041571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1.5-T MR relaxometry in quantifying splenic and pancreatic iron: retrospective comparison of a commercial 3D-Dixon sequence and an established 2D multi-gradient echo sequence.
    Plaikner M; Lanser L; Kremser C; Weiss G; Henninger B
    Eur Radiol; 2023 Jul; 33(7):4973-4980. PubMed ID: 36800012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregressive moving average modeling for hepatic iron quantification in the presence of fat.
    Tipirneni-Sajja A; Krafft AJ; Loeffler RB; Song R; Bahrami A; Hankins JS; Hillenbrand CM
    J Magn Reson Imaging; 2019 Nov; 50(5):1620-1632. PubMed ID: 30761652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.
    Li J; Lin H; Liu T; Zhang Z; Prince MR; Gillen K; Yan X; Song Q; Hua T; Zhao X; Zhang M; Zhao Y; Li G; Tang G; Yang G; Brittenham GM; Wang Y
    J Magn Reson Imaging; 2018 Oct; 48(4):1069-1079. PubMed ID: 29566449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.